Home    Back

Teduglutide 0.2 mg    (DrugBank: Teduglutide)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00072839
(ClinicalTrials.gov)		October 200311/11/2003Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's DiseaseA Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's DiseaseCrohn's DiseaseDrug: ALX-0600;Drug: placebo;Drug: teduglutide 0.05;Drug: teduglutide 0.2 mg;Drug: Teduglutide 0.05 dose;Drug: teduglutide 0.1 mg doseShireNULLCompleted18 YearsN/ABoth100Phase 2United States;Canada